A consideration of CYP2D6 genetic variations in the Ghanaian population as a potential 'culprit' for the tramadol 'abuse crisis'.

Journal Information

Full Title: BMC Med Genomics

Abbreviation: BMC Med Genomics

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics, Medical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"raw data has been deposited in geo submission with accession number gse232865."

Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateAll experimental protocols involving human data was in accordance with relevant national and international guidelines and regulations. This study received ethical approval from the Cape Coast Teaching Hospital Ethical Review Committee (CCTHERC/EC/2020/2020/109) under the PHARMABIOME project. All participants provided both written and verbal consent to be part of this study. All participants provided both written and oral informed consent before samples were taken. Consent for publicationNot Applicable. Competing interestsAuthors declare no conflict of interest. Author informationN/A. Competing interests Authors declare no conflict of interest."

Evidence found in paper:

"Funding Dr Nicholas Ekow Thomford and the Pharmacogenomics and Genomic Medicine Group and Lab (http://pgmg-lab.com) received funding from the European and Developing Countries Clinical Trials Partnership (EDCTP), Netherlands- fund number: TMA2019CDF-2670."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025